NCT01130025 - Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer | Biotech Hunter

Enrollment

900

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions

Venous Thromboembolism

Interventions

DRUG

Warfarin

Tablets. Once daily for 6 months (180 days) to maintain therapeutic international normalised ratio (INR) levels in combination with initial (5-10 days) overlapping treatment with Innohep®.

DRUG

Innohep®

Solution for sub-cutaneous injection, pre-filled syringes. Once daily for 6 months (180 days). 175 anti Xa IU/kg.

Trial Locations (1)

BC V5Z 1M9

Diamond Health Care Centre, Vancouver